- Home
- NMIH vs HCM Comparison
NMIH vs HCM Comparison
Compare NMIH & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMIH
- HCM
- Stock Information
- Founded
- NMIH 2011
- HCM 2000
- Country
- NMIH United States
- HCM Hong Kong
- Employees
- NMIH N/A
- HCM N/A
- Industry
- NMIH Property-Casualty Insurers
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- NMIH Finance
- HCM Health Care
- Exchange
- NMIH Nasdaq
- HCM Nasdaq
- Market Cap
- NMIH 3.1B
- HCM 2.6B
- IPO Year
- NMIH 2013
- HCM N/A
- Fundamental
- Price
- NMIH $39.03
- HCM $17.54
- Analyst Decision
- NMIH Buy
- HCM
- Analyst Count
- NMIH 6
- HCM 0
- Target Price
- NMIH $42.33
- HCM N/A
- AVG Volume (30 Days)
- NMIH 305.2K
- HCM 55.4K
- Earning Date
- NMIH 11-05-2025
- HCM 08-07-2025
- Dividend Yield
- NMIH N/A
- HCM N/A
- EPS Growth
- NMIH 11.30
- HCM N/A
- EPS
- NMIH 4.71
- HCM 0.53
- Revenue
- NMIH $679,621,000.00
- HCM $602,197,000.00
- Revenue This Year
- NMIH N/A
- HCM $2.73
- Revenue Next Year
- NMIH $5.15
- HCM $17.33
- P/E Ratio
- NMIH $8.29
- HCM $6.26
- Revenue Growth
- NMIH 9.99
- HCM N/A
- 52 Week Low
- NMIH $31.90
- HCM $11.51
- 52 Week High
- NMIH $43.20
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- NMIH 46.15
- HCM 61.45
- Support Level
- NMIH $39.22
- HCM $15.51
- Resistance Level
- NMIH $40.45
- HCM $18.30
- Average True Range (ATR)
- NMIH 0.62
- HCM 0.33
- MACD
- NMIH -0.05
- HCM 0.28
- Stochastic Oscillator
- NMIH 15.48
- HCM 78.95
About NMIH NMI Holdings Inc.
NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.